Xencor develops antibody-based medicines for cancer and immune diseases. Its products and research services support pharmaceutical partners, healthcare providers, and patients through drug discovery, clinical development, and licensing.
Xencor products and services overview:
Revenue: ~$128 million
Employees: 300
Headquarters: Pasadena, United States (USA)
Xencor is one of the...
Xencor is a company listed under the stock ticker XNCR (US).
View the org chart displaying its 18 main executives
Create your alert
to follow the executive moves at Xencor.
Xencor has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.